3D model is for representation purpose only.
.
.
![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                    
                        
|---|---|---|---|---|
| GGGGG | propyl | Camptothecin | 
| Identification | |
|---|---|
| ConjuPepDB ID |   cpd01535  | 
| Smiles | |
| Molecular weight |   706.271  | 
| Molecular formula |   C33H38N8O10  | 
| Chemical name | Peptide information | 
| Sequence (one letter) |   GGGGG  | 
| Length |   5  | 
| Peptide name |   oligoglycin  | 
| External ID | |
|---|---|
| CAS number |   330808-07-6  | 
| Other information | |
|---|---|
| Application |   Synthesis  | 
| Pharmacological class |   anticancer  | 
| Conjugate type |   amide  | 
| Linker |   N/A  | 
| Linker Type |   propyl  | 
| Small molecule |   Camptothecin  | 
| Small molecule CAS |   7689-03-04  | 
| Calculated properties | |
|---|---|
| LogP |   -5.20087  | 
| Rotatable bonds |   15  | 
| H bond donor |   7  | 
| H bond acceptor |   11  | 
| Polar surface area (PSA) |   260.48000  | 
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI | 
Determinants for the drug release from T-0128, camptothecin analog-carboxymethyl dextran conjugate  | 2000  | Harada, M.; Sakakibara, H.; Yano, T.; Suzuki, T.; Okuno, S.  | Journal of Controlled Release  | ||